Unlock instant, AI-driven research and patent intelligence for your innovation.

Construction method and application of IL1RAP gene humanized non-human animal

A non-human animal, humanized technology, applied in the field of animal genetic engineering and genetic modification, biomedicine, can solve the problem of successful construction of humanized animals without IL1RAP gene, and no disclosure of exogenous nucleotide sequence IL1RAP gene human source issues such as transformation

Inactive Publication Date: 2022-08-02
BIOCYTOGEN JIANGSU CO LTD +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Different gene sequences, structures, and functions make it impossible to simply apply a gene humanization transformation plan to another gene humanization transformation
[0004] In the prior art, there is no successful construction of IL1RAP gene humanized animals, and there is no disclosure of the foreign nucleotide sequence specifically selected by the application for IL1RAP gene humanized transformation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Construction method and application of IL1RAP gene humanized non-human animal
  • Construction method and application of IL1RAP gene humanized non-human animal
  • Construction method and application of IL1RAP gene humanized non-human animal

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1I

[0236] Example 1IL1RAP gene humanized mice

[0237] Mouse IL1RAP gene (NCBI Gene ID: 16180, Primary source: MGI: 104975, UniProt: Q61730, located at positions 26400259 to 26548878 of chromosome 16 NC_000082.7, based on transcript NM_008364.2 and its encoded protein NP_032390.1 ( SEQ ID NO: 1)) and human IL1RAP gene (NCBI Gene ID: 3556, Primary source: HGNC: 5995, UniProt ID: Q9NPH3, located at positions 190514085 to 190659750 of chromosome 3 NC_000003.12, based on transcript NM_001167929.2 The comparison schematic diagram of its encoded protein NP_001161401.1 (SEQ ID NO: 2)) is as follows figure 1 shown.

[0238] In order to achieve the purpose of the present invention, a nucleotide sequence encoding human IL1RAP protein can be introduced into the mouse endogenous IL1RAP locus, so that the mouse expresses human or humanized IL1RAP protein, and there are various alternative ways. For example, using gene editing techniques, sequences encoding the human signal peptide and extra...

Embodiment 2

[0267] Example 2 Preparation of double humanized or multiple double humanized mice

[0268] Using this method or the prepared IL1RAP gene humanized mouse model can also be used to prepare double or multiple humanized mouse models. For example, in the aforementioned Example 1, embryonic stem cells used for blastocyst microinjection can be selected from mice with other genetic modifications such as IL33, PD-L1, IL10, IL1B, IL1R1, IL13, IL17, CCR5, CCR8, etc., or , or on the basis of humanized IL1RAP mice, the mouse ES embryonic stem cell isolation and gene recombination targeting technology can be used to obtain IL1RAP and other gene-modified double-gene or multi-gene-modified mouse models. The IL1RAP mouse homozygote or heterozygote obtained by this method can also be mated with other gene-modified homozygous or heterozygous mice, and the offspring are screened. According to the law of Mendelian inheritance, there is a certain probability to obtain humanized IL1RAP. With other...

Embodiment 3

[0269] Embodiment 3 drug efficacy verification

[0270] The IL1RAP humanized mice prepared by this method can be used to evaluate the efficacy of drugs targeting human IL1RAP. For example, IL1RAP humanized mouse homozygotes were subcutaneously inoculated with mouse colon cancer cells MC38. After the tumor volume grew to about 100 mm3, it was divided into a control group or a treatment group according to the tumor volume. The treatment group randomly selected drugs targeting human IL1RAP. The control group was injected with an equal volume of normal saline or PBS. Regularly measure the tumor volume and weigh the body weight of the mice, and the in vivo safety and efficacy of the drug can be effectively assessed by comparing the changes in the body weight of the mice and the tumor size.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an IL1RAP gene humanized non-human animal and a construction method thereof, a humanized IL1RAP protein, a humanized IL1RAP gene, a targeting vector of the IL1RAP gene and application of the targeting vector in the field of biological medicine, and a nucleotide sequence for coding the human IL1RAP protein is introduced into a non-human animal genome in a homologous recombination mode; the human or humanized IL1RAP protein can be normally expressed in the animal body, and the human IL1RAP protein can be used as an animal model for human IL1RAP signal mechanism research and tumor and autoimmune disease drug screening, and has important application value for new drug research and development of immune targets.

Description

technical field [0001] The invention belongs to the field of animal genetic engineering and genetic modification, in particular to a method for constructing a non-human animal model of IL1RAP gene modification and its application in the field of biomedicine. Background technique [0002] Interleukin-1 receptor accessory protein (IL1RAP or IL-1RAcP), also known as interleukin-1 receptor 3 (IL-1R-3 or IL-1R3), belongs to the interleukin-1 (IL-1) ) receptor family, which is an essential part of the IL-1 receptor complex and mediates pathways such as IL-1-dependent NFkB activation. IL1RAP contains 3 IGG-like C2-type (immunoglobulin-like) domains and 1 TIR domain, and is mainly expressed in tissues with IL1, IL33 or IL36 receptors, such as lymph nodes (thymus, tonsils), bone marrow, brain, lung , skin, intestine, liver and placenta. IL1RAP has been shown to be integral to the transmission of IL-1, IL-33, and IL-36 signaling, and to induce and induce adhesion molecules, cytokine...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/715C12N15/12C12N15/85C12N5/10A01K67/027G01N33/574G01N33/68C12Q1/02A61P35/00A61P37/02A61K49/00A61K45/00
CPCC07K14/7155C12N15/8509C12N5/0693A01K67/0275G01N33/57484G01N33/6893G01N33/5011G01N33/5008A61K45/00A61P35/00A61P37/02A61K49/0008C12N2800/60C12N2510/00A01K2227/105A01K2267/03G01N2800/7028G01N2800/24G01N2333/7155Y02A50/30A01K2217/072A01K2207/15A01K2267/0331
Inventor 周小飞尚诚彰刘重慧
Owner BIOCYTOGEN JIANGSU CO LTD